牛津大学医院通过创新和团队合作,在2024-25年领导英国成人活肾移植。 Oxford University Hospitals led UK adult living kidney transplants in 2024-25 via innovation and teamwork.

根据国家卫生服务局血液和移植年度报告,牛津大学医院NHS基金会信托基金被命名为联合王国2024-25年成人活肾移植方面表现最好的NHS信托。 Oxford University Hospitals NHS Foundation Trust has been named the top-performing NHS trust in the UK for adult living kidney transplants in 2024-25, according to NHS Blood and Transplant’s annual report. 尽管信托基金规模中等,但通过采用多学科办法提高效率和患者结果,其业绩超过大型中心。 Despite its medium size, the trust outperformed larger centers by improving efficiency and patient outcomes through a multidisciplinary approach. 主要改进包括团体捐助者研讨会、评估前问卷、海外捐助者虚拟评价、精简成像、扩大独立评估员和外科手术后备系统。 Key improvements included group donor seminars, pre-assessment questionnaires, virtual evaluations for overseas donors, streamlined imaging, expanded independent assessors, and backup systems for surgery. 该信托基金在国家生活捐助者肾脏分享计划中发挥了主要作用,通过该方案促进了大约三分之一的移植,并与考文垂医院合作,增加资源和专门知识。 The trust played a major role in the National Living Donor Kidney Sharing Scheme, with about one-third of transplants facilitated through the program, and collaborated with Coventry Hospital to enhance resources and expertise. 成功归功于团队合作、创新,以及注重更快、更安全和更支持病人和捐助者的护理。 Success was attributed to teamwork, innovation, and a focus on faster, safer, and more supportive care for patients and donors.